1204-35-9

应用筛选条件

关键词:'1204-35-9'

显示 1-10 #N/A 957 条结果关于 "1204-35-9" 范围网站内容

胃肠道癌症中的免疫组织化学应用

结直肠癌是男性和女性中第三大常见癌症。预计2016年将发生136,000例结直肠癌。

Special Savings - Save up to 35% on our Materials Science Products!

Materials Science Products Special end-of-year discount page.

X-tremeGENE™ 9 DNA Transfection Reagent Protocol

Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).

CRISPR Cas 9 Nuclease RNA-guided Genome Editing

Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.

Color Determination of sugar based on ICUMSA Color GS2-9

Learn about the ICUMSA® Method GS2-9 (2024) to measure the color of sample solutions of white sugar or highly pure sugar syrup of color index up to 600 IU.

X-tremeGENE™ 9 DNA转染试剂实验方案

约转染前24小时接种细胞，确保细胞处于最佳密度（7090 %融合度）。

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Responds to global demand for biosafety testing for drug development and commercialization. Expansion creates nearly 500 new jobs in Glasgow and Stirling. Company’s investment to boost global testing capacity now tops € 350 million since mid-2022.

Endotoxin-free Plasmid DNA Purification

GenElute HP Plasmid Maxiprep Kit isolates endotoxin-free plasmid DNA in 35 minutes, meeting industry standards.

Merck Expands in Gillingham, UK, Boosts Distribution Capabilities

Merck today announced the completion of a £9 million expansion to its Gillingham distribution center.

Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months

The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.

1/96